The main trends of the research from 2000 to 2018 were C-reactive protein, endometrial cancer, metastasis, chemoresistance etc. The main trends of the research from 2018 to 2024 were inflammation, cytokines, survival, biomarkers, prognosis, immunotherapy etc. However, the frequencies of ovarian cancer, inflammation and prognosis were relatively high. This evidence concerns the gene CRP and endometrial cancer.